https://www.avient.com/news/hai-prevention-has-ally-new-polyone-tpes-feature-enhanced-resistance-antiseptics
New Versaflex™ HC overmolding thermoplastic elastomers (TPEs) for medical device housings offer enhanced resistance to commonly used antiseptic cleaners.
Customers have reported that devices made with Versaflex HC TPEs successfully withstood 10,000 antiseptic wipes.
Both grades, designed for two-shot injection molding, provide a soft touch and grippy feel to enhance ergonomics, comfort and ease of use for housings of hand-held scanners, patient monitors, infusion pumps, defibrillators, reusable surgical devices and other durable medical devices.
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520Investor%2520Day%25205-18-15.pdf
The non-GAAP financial measures
include: adjusted EPS, earnings before interest, tax, depreciation and amortization
(EBITDA), adjusted EBITDA, net debt, Specialty platform operating income, Specialty
platform gross margin percentage, adjusted operating income, return on invested
capital, net debt/ EBITDA, and the exclusion of corporate charges in certain
calculations
Addressable market exceeds $40 billion
• Strong performance demonstrates that our strategy and execution
are working
• Megatrends and emerging opportunities align with our strengths
• Innovation and services provide differentiation, incremental pricing
power, and competitive advantage
• Strong and proven management team driving growth and
performance
PolyOne Corporation Page 92
Questions & Answers
Schedule I
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented
in accordance with U.S.
Adjusted net cash provided by operating activities is calculated as follows:
2008Y 2009Y 2010Y 2011Y 2012Y 2013Y 2014Y
Net cash provided by operating activities $ 72.5 $ 229.7 $ 140.8 $ 72.5 $ 106.9 $ 109.0 $ 208.4
Dividends and distributions received from joint ventures (32.9) (36.5) (24.2) (6.0) - - -
Pension Cash Contributions 35.9 28.5 37.5 38.1 68.8 69.8 21.6
Adjusted net cash provided by operating activities $ 75.5 $ 221.7 $ 154.1 $ 104.6 $ 175.7 $ 178.8 $ 230.0
Net debt to adjusted EBITDA is calculated as follows:
Twelve Months Ended
(In millions) December 31, 2011 December 31, 2012 December 31, 2013 December 31, 2014
Short-term portion and current portion of
long-term debt $ 3.0 $ 3.8 $ 12.7 $ 61.8
Long-term debt 704.0 703.1 976.2 962.0
Less: Cash and cash equivalents (191.9) (210.0) (365.2) (238.6)
Net Debt $ 515.1 496.9 623.7 785.2
Income before income taxes $ 168.9 $ 83.3 $ 151.0 $ 88.4
Interest expense, net 33.7 50.8 63.5 62.2
Depreciation and amortization 53.2 65.8 108.8 123.9
Equity income from equity affiliates (5.7) - - -
Special items, impact on income before
income taxes (48.1) 55.1 46.3 164.9
Interest expense included in special items - (1.3) (1.9) -
Accelerated depreciation included in special
items - - (12.7) (23.1)
Adjusted EBITDA $ 202.0 $ 253.7 $ 355.0 $ 416.3
Net Debt/Adjusted EBITDA 2.6 2.0 1.8 1.9
Investor Day - May 18 2015 r11
Investor Day - May 18 2015
POL IR Presentation - Investor Day - 5_13_15 Master Version WEBSITE
Investor Day
Forward-Looking Statements
Use of Non-GAAP Measures
Agenda
Introduction��
Slide Number 6
The Leaders Behind the Team
Commodity to Specialty Transformation
Proof of Performance
Mix Shift Highlights Specialty Transformation
Proof of Performance
Successfully Navigating Change Since 2012
Strategy and Execution Drive Results
Well Positioned for Accelerated Growth
Global Color, Additives & Inks��
At a Glance
A Case Study for Transformational Success
Slide Number 18
Accelerating Growth
Who We Are Growing With
Innovation Pipeline Potential
Megatrends Aligned with Key End Markets
Key Initiatives
Platinum Vision
Summary
Global Specialty Engineered Materials��
What We Do
At a Glance
A Case Study for Transformational Success
Slide Number 30
Accelerating Growth
Who We Are Growing With
Innovation Pipeline Potential
Megatrends Aligned with Key End Markets
Key Initiatives
Platinum Vision
Summary
�Designed Structures and Solutions��
At a Glance
Early Progress
A Lot of Work Remains with Tremendous Upside Potential
Innovating with Cross-Business Unit Technologies
Who We Are Growing With
Key Initiatives
Platinum Vision
Summary
Performance Products and Solutions��
At a Glance
What We Have Delivered
Slide Number 50
Accelerating Growth
Who We Are Growing With
Geographic Growth Opportunities
Innovation Pipeline Potential
Megatrends Aligned with Key End Markets
Key Initiatives
Platinum Vision
Summary
PolyOne Distribution��
At a Glance
Slide Number 61
What We Have Delivered
Accelerating Growth
Who We Are Growing With
Megatrends Aligned with Key End Markets
Geographic Growth Opportunities
Going Beyond Distribution
Platinum Vision
Summary
Financial Highlights��
Who We Are Growing With
2014 Awards and Recognitions
2014 Financial Highlights
Proof of Performance & 2015 Targets
Ours is Not a Cost Cutting Story
Financial Strength
Financial Flexibility
Cash to Generate Value
Slide Number 79
Slide Number 80
2020 Platinum Vision��
PolyOne Core Values
Confirmation of Our Strategy
Strategy and Execution Drive Results
Formula for Success
Track Record of Successful Acquisitions
Driving Toward Premier Profitability
2020 Platinum Vision
Platinum Vision: Pathway to Accelerated Growth
Driving Toward a Premium Specialty Multiple
Why Invest In PolyOne?